Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Garlic + nystatin is a combination of two agents—garlic (a natural product with antifungal and anti-inflammatory properties) and nystatin (a polyene antifungal drug)—used or studied together for the treatment of fungal infections, particularly oral candidiasis such as denture stomatitis. Nystatin acts by binding to ergosterol in fungal cell membranes, increasing membrane permeability and causing cell death. Garlic contains allicin, which exhibits antifungal activity through disruption of microbial membranes and modulation of inflammatory responses. Clinical studies have compared the efficacy of garlic extract to nystatin in treating denture stomatitis, finding both effective but with greater patient satisfaction reported for garlic due to fewer side effects[1][2][7]. This combination is not a standard pharmaceutical product but may be used in alternative or adjunctive therapy settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on garlic + nystatin.